29720 Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices 

(9780), a basic class of controlled 

substance listed in schedule II. 

The company plans to bulk 

manufacture the above listed controlled 

substance for distribution to its 

customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA 22152; and must be 

filed no later than August 24, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–14705 Filed 6–22–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

DRUG ENFORCEMENT 

ADMINISTRATION 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to Section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on May 1, 

2009, Noramco Inc., Division of OrthoMcNeil, Inc., 1440 Olympic Drive, 

Athens, Georgia 30601, made 

application by letter to the Drug 

Enforcement Administration (DEA) for 

registration as a bulk manufacturer of 

Noroxymorphone (9668), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to bulk 

manufacture the above listed controlled 

substance for distribution to its 

customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA 22152; and must be 

filed no later than August 24, 2009. 

Dated: June 15, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–14704 Filed 6–22–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to Section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on May 22, 

2009, Noramco Inc., Division of OrthoMcNeil, Inc., 500 Swedes Landing Road, 

Wilmington, Delaware 19801, made 

application by letter to the Drug 

Enforcement Administration (DEA) for 

registration as a bulk manufacturer of 

Tapentadol (9780), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to bulk 

manufacture the above listed controlled 

substance for distribution to its 

customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such a substance, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA 22152; and must be 

filed no later than August 24, 2009. 

Dated: June 15, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–14695 Filed 6–22–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary; ‘‘Promotion of 

Labor Rights and Employment in 

Pakistan’’ 

June 17, 2009. 

AGENCY: Bureau of International Labor 

Affairs, Department of Labor. 

Announcement Type: New. Notice of 

Availability of Funds and Solicitation 

for Cooperative Agreement 

Applications. The full announcement is 

posted on http://www.Grants.gov. 

Funding Opportunity Number: SGA– 

09–07. 

Key Dates: The closing date for receipt 

of applications is July 31, 2009 via 

Grants.gov. Applications may also be 

submitted by mail. 

Funding Opportunity Description 

The U.S. Department of Labor 

(USDOL), Bureau of International Labor 

Affairs (ILAB), announces the 

availability of funds in the amount of 

U.S. $1,600,000 to be awarded by 

Cooperative Agreement to a qualifying 

organization for the purpose of 

implementing a worker rights and 

employment demonstration project that 

assists unemployed Pakistanis with 

vocational and entrepreneurial training 

to obtain employment or pursue 

professions and acquire an 

understanding of their fundamental 

rights as workers. The project will take 

place in the Federally Administered 

Tribal Areas, the Northwest Frontier 

Province and Baluchistan. Participants 

provided with vocational training will 

also receive integrated worker rights 

training in order to ensure that they are 

able to fully benefit from their new 

skills and professions. Similarly, new 

entrepreneurs may become employers 

for the first time and will also receive 

worker rights training to understand 

their responsibilities as employers. 

ILAB is authorized to award and 

administer this program by the 

Department of Labor Appropriations 

Act, 2009, Public Law 111–08, 123 Stat. 

524 (2009). The Cooperative Agreement 

awarded under this initiative will be 

managed by ILAB’s Office of Trade and 

Labor Affairs. The duration of the 

project funded by this solicitation is 

three years. The start date of program 

activities will be negotiated upon award 

of the Cooperative Agreement, but will 

be no later than September 30, 2009. 

The full Solicitation for Grant 

Applications is posted on http:// 

www.Grants.gov under U.S. Department 

of Labor/ILAB. If you need to speak to 

a person concerning these grants, or if 

you have issues regarding access to the 

Grants.gov Web site, you may telephone 

Georgiette Nkpa at 202–693–4584 (not a 

toll-free number). 

Signed at Washington, DC this 17th day of 

June 2009. 

Cassandra Mitchell, 

Grant Officer. 

[FR Doc. E9–14648 Filed 6–22–09; 8:45 am] 

BILLING CODE 4510–28–P